Therefore, PDT employs a multifaceted mechanism to modulate CRC angiogenesis, involving both direct damage to tumor vasculature and the regulation of oxidative stress response and VEGF expression within the tumor microenvironment. The gene discussed is VEGFA; the disease is neoplasm.